AlphaFold predicted structure
MECOM · Q03112

Mean pLDDT
50.4/ 100
Low
1,230 residues
Confidence breakdown
- Very high(≥ 90)0%
- Confident(70–90)25%
- Low(50–70)8%
- Very low(< 50)66%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
MDS1 and EVI1 complex locus
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Bleeding and platelet disorders
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownCytopenia - NOT Fanconi anaemia
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedDDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownInherited bleeding disorders
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownLimb disorders
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedPrimary immunodeficiency or monogenic inflammatory bowel disease
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedRadio-ulnar synostosis - amegakaryocytic thrombocytopenia
radioulnar synostosis with amegakaryocytic thrombocytopenia 2
MECOM-associated syndrome
congenital radioulnar synostosis
hypertensive disorder
glaucoma
preeclampsia
open-angle glaucoma
asthma
prostate carcinoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Histone-lysine N-methyltransferase MECOM
Functions as a transcriptional regulator binding to DNA sequences in the promoter region of target genes and regulating positively or negatively their expression. Oncogene which plays a role in development, cell proliferation and differentiation. May also play a role in apoptosis through regulation of the JNK and TGF-beta signaling. Involved in hematopoiesis
Curated MONDO disease pages that list MECOM among their top associated genes.
MECOM · Q03112

Mean pLDDT
50.4/ 100
Low
1,230 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0